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H.B.T. is Special Editor of the Imaging Theme Issue.Over the past decade, imaging devices for small animals
have evolved from little more than boutique instruments,
limited in many cases to the largest academic institutions, to
extremely useful tools facilitating bench to bedside trans-
lational research at many colleges, universities, and phar-
maceutical companies. It long has been known that a wealth
of information can be garnered from noninvasive, longitu-
dinal imaging studies performed in humans. However, the
ability to perform similar studies in preclinical models, such
as rodents, required a signiﬁcant investment by both the
equipment manufacturers and partnering academic labora-
tories to reverse engineer clinical imaging capabilities into
small animaleenabled workstations. As a result of these
partnerships, current imaging modalities are now applicable
to small animals in the form of magnetic resonance imaging
(MRI), computed tomography (CT), positron emission tomo-
graphy (PET), single photon emission computed tomography
(SPECT), bioluminescence imaging, ultrasound, and intravital
imaging.
Noninvasive Imaging Studies
Advances in using small animals as models that more
faithfully recapitulate the human disease state in combi-
nation with technological advances in instrumentation
hardware and software have positioned researchers in the
ﬁeld of small animal imaging to make unique contributions
to medicine. Multimodality imaging and theranosticsdthe
combination of diagnostics and therapeuticsdhave be-
come increasingly important with advances in nanotech-
nology and molecular imaging. These combinations offer
unique opportunities to study tissue metabolism and
function as well as anatomy in small animal models of
human disease.Copyright ª 2013 American Society for Investigative Pathology.
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http://dx.doi.org/10.1016/j.ajpath.2012.11.015In the early days there was a skepticism regarding the use
of small animal imaging in models of human disease. This
skepticism was underscored by the authors’ own personal
experience when, in 1999, we submitted a manuscript
describing the use of cardiac MRI to study the evolution of
Chagas cardiomyopathy in the mouse model.1 One reviewer
stated that it was unclear why we wanted to do these exper-
iments and suggested that we simply infect mice and at
various intervals sacriﬁce them and evaluate the pathology.
The notion of serial, longitudinal, noninvasive studies on
a single mouse over time was never considered by the
reviewer. Interestingly, since that time many subsequent
papers both by our group and, more importantly by others,
have indeed used serial echocardiography, cardiac MRI, and
microPET to evaluate cardiac structure and function in
murine models of Chagas disease. In fact, many journals will
not accept papers on small animal models of human heart
diseases without these types of structural and functional
studies.
Perhaps predictably, PubMed is ever-growing in its
inclusion of papers devoted to anatomical and functional
imaging. A search of the term preclinical imaging returns
71 papers listed in 1999 to more 650 in 2011 (http://www.
ncbi.nlm.nih.gov/pubmed, last accessed November 2012).
Such experiments, combined with initiatives to follow drug
delivery, develop contrast agents, and provide image-guided
therapy in small animals, are now openly integrated with
clinical applications. This reciprocal cross-fertilization
between clinical and preclinical imaging promises to
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Figure 1 Historically, clinical imaging has informed preclinical imaging
and visa versa. This close association allows for the free exchange of ideas,
approaches, and data, as well as complementation of clinical ﬁndings using
animal models when necessary.
Guest Editorialaccelerate advances in novel imaging applications and
quicken the development of new technologies and their uses
(Figure 1).The American Journal of Pathology - ajp.amjpathol.orgImaging Theme Issue
The reviews in this special Imaging Theme Issue of The
American Journal of Pathology provide an overview of
recent advances in small animal imaging and applications to
studies of infectious diseases and cancer. These reviews are
not meant to be an exhaustive treatment of the subject but
rather a targeted introduction to afford those who are
interested in a reference point to perform their own in-depth
assessment of these modalities.
Since preclinical MRI, PET, CT, SPECT, and ultrasound
imaging have been extensively applied to animal models of
cancer and infectious diseases, and bioluminescence has
been shown to be a powerful technique for tracking
tumorigenesis, bacteria, fungi, parasites, and viruses, we
anticipate that more researchers and their institutions will
recognize the value that noninvasive preclinical imaging
provides, furthering its integration into basic and trans-
lational research.Reference
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